Inventiva SA (IVA)
2.67
-0.24
(-8.25%)
USD |
NASDAQ |
Jun 21, 16:00
2.80
+0.13
(+4.87%)
After-Hours: 20:00
Inventiva Shareholders Equity (Quarterly): -35.41M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -35.41M |
| June 30, 2023 | -8.332M |
| June 30, 2023 | -8.332M |
| December 31, 2022 | 48.77M |
| June 30, 2022 | 72.84M |
| June 30, 2022 | 72.84M |
| June 30, 2021 | 105.34M |
| March 31, 2021 | 119.87M |
| June 30, 2020 | 46.93M |
| December 31, 2019 | 46.37M |
| Date | Value |
|---|---|
| June 30, 2019 | 47.32M |
| June 30, 2019 | 47.32M |
| December 31, 2018 | 70.46M |
| June 30, 2018 | 90.64M |
| June 30, 2018 | 90.64M |
| December 31, 2017 | 74.25M |
| June 30, 2017 | 81.27M |
| June 30, 2017 | 81.27M |
| December 31, 2016 | 37.49M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.41M
Minimum
Dec 2023
119.87M
Maximum
Mar 2021
46.29M
Average
47.32M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 111.65M |
| Cellectis SA | 90.57M |
| Genfit SA | 75.11M |
| Innate Pharma SA | 57.37M |
| Nanobiotix SA | -2.038M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.89M |
| Total Liabilities (Quarterly) | 112.30M |
| Debt to Equity Ratio | -0.9654 |
| Current Ratio | 0.9607 |
| Net Debt Paydown Yield | -2.57% |